- MS-20 is a mixture of soybean fermentation metabolites which is produced in strictly controlled fermenter and with carefully chosen microorganisms that mimics the human intestinal environment.
- The manufacturing and R&D procedures of Chemo young follow the international regulations.MS-20 was approved as the new drug by MOHW in 2011.
- MS-20 can promote the growth of probiotics and act as an immunomodulator to improve immunity and inhibit tumor growth.
- MS-20 is the first and the only oral new drug for ameliorating fatigue and appetite loss in patients receiving chemotherapy and thus improves the quality of life.
- MS-20 is estimated to be approximately NT$4.5 billion in the Taiwan market, with an annual increase of 90,000 cancer patients. The number of cancer patients worldwide will reach 1.4 million, and medical needs will exceed $20 billion annually.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.